(Q43141937)

14 November 2017

title

Potential clinical and economic impact of nonadherence with osteoporosis medications (English)

1 reference

14 November 2017

0 references

5

Jean-Yves Reginster

1 reference

14 November 2017

Mickaël Hiligsmann

1

1 reference

14 November 2017

Véronique Rabenda

series ordinal

2

1 reference

14 November 2017

Henry-Jean Gathon

series ordinal

3

1 reference

14 November 2017

Olivier Ethgen

series ordinal

4

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Calcified Tissue International

14 November 2017

published in

1 reference

14 November 2017

volume

86

1 reference

14 November 2017

issue

3

1 reference

14 November 2017

page(s)

202-210

1 reference

https://scigraph.springernature.com/pub.10.1007/s00223-009-9329-4

14 November 2017

exact match

0 references

cites work

Medication compliance and persistence: terminology and definitions

1 reference

https://api.crossref.org/works/10.1007%2FS00223-009-9329-4

Crossref

reference URL

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-009-9329-4

Crossref

reference URL

10.1007/S00223-009-9329-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 November 2017

1003285066

0 references

1 reference